Screener
Xenetic Biosciences XBIO Q4 2025 Annual earnings
Reported March 12, 2026 · After market close
Revenue$766.3KBeat by $76.3K
EPS-$0.22Beat by $0.30
Revenue estimate$690.0K
EPS estimate-$0.52
Next report
Nov 6, 2026 (in 2 months)Versus estimates
Revenue
Q2 2026$660.6KQ1 2026$806.9K
Q4 2025$766.3KBeat by $76.3K
Q3 2025$1.0MBeat by $397.0KQ2 2025$589.9KBeat by $110.9KQ1 2025$593.3KBeat by $77.3KDiluted EPS
Q2 2026-$0.41Q1 2026-$0.20
Q4 2025-$0.22Beat by $0.30
Q3 2025-$0.33Beat by $0.16Q2 2025-$0.45Beat by $0.19Q1 2025-$0.59Beat by $0.13FAQ
- When did Xenetic Biosciences report Q4 2025 earnings?
- Xenetic Biosciences (XBIO) reported Q4 2025 earnings on March 12, 2026 after market close.
- What were Xenetic Biosciences's Q4 2025 revenue and EPS?
- Xenetic Biosciences reported revenue of $766.3K and eps of $-0.22 for Q4 2025.
- Did Xenetic Biosciences beat estimates in Q4 2025?
- Revenue beat the consensus estimate of $690.0K by $76.3K. EPS beat the consensus estimate of $-0.52 by $0.30.
- How did Xenetic Biosciences's Q4 2025 results compare year-over-year?
- Compared to the same quarter a year prior, revenue grew 18.1% from $648.8K a year earlier and eps grew 67.8% from $-0.68.
- Where can I find Xenetic Biosciences's Q4 2025 SEC filings?
- You can read the 8-K earnings release (0001683168-26-001744) and the 10-K periodic report (0001683168-26-001737) directly on SEC EDGAR. The filing index links above go to sec.gov.
